Key Market Indicators
Portugal's blood and blood forming organs medicine sales are expected to reach an estimated $369.5 million by 2026, growing at a CAGR of 2.8% since 2021. This is up 9.8% from 2005. In 2021, Denmark overtook Portugal in sales, with $310.4 million. Germany, Italy, and South Korea were ranked second, third, and fourth, respectively. In 2019, the prevalence of anemia in Portugal was at 4,650 hospital discharges, up 0.4% from the previous year. Since 2000, however, the demand has decreased by 2.2% year-on-year. Lithuania overtook Portugal in 2019, with 4,650 hospital discharges. Germany, the United Kingdom, and Poland took the next three spots.
